Patents by Inventor Michelle RATLIFF

Michelle RATLIFF has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-ARID3A TREATMENTS FOR INFLAMMATORY DISORDERS
    Publication number: 20210180063
    Abstract: Antisense compounds for suppressing expression of ARID3a are disclosed, as well as pharmaceutical compositions containing same and methods of producing and using same. The antisense compounds can be used to treat inflammatory disorders and conditions related to interferon-alpha production.
    Type: Application
    Filed: December 1, 2020
    Publication date: June 17, 2021
    Inventors: Carol F. Webb, Julie Ward, Michelle Ratliff
  • Anti-ARID3a treatments for inflammatory disorders
    Patent number: 10876116
    Abstract: Antisense compounds for suppressing expression of ARTD3a are disclosed, as well as pharmaceutical compositions containing same and methods of producing and using same. The antisense compounds can be used to treat inflammatory disorders and conditions related to interferon-alpha production.
    Type: Grant
    Filed: July 14, 2017
    Date of Patent: December 29, 2020
    Assignee: The Board of Regents of the University of Oklahoma
    Inventors: Carol F. Webb, Julie Ward, Michelle Ratliff
  • ANTI-ARID3A TREATMENTS FOR INFLAMMATORY DISORDERS
    Publication number: 20190345493
    Abstract: Antisense compounds for suppressing expression of ARTD3a are disclosed, as well as pharmaceutical compositions containing same and methods of producing and using same. The antisense compounds can be used to treat inflammatory disorders and conditions related to interferon-alpha production.
    Type: Application
    Filed: July 14, 2017
    Publication date: November 14, 2019
    Inventors: Carol F. WEBB, Julie WARD, Michelle RATLIFF